NON-HODGKIN'S LYMPHOMA

Refine Results:
All Categories Epidemiology and Etiology (191) Prevention and Screening (54) Diagnosis and Staging (268) Treatment (534) Supportive Oncology (51)

CME

Advances in the Management of B-Cell and T-Cell Lymphomas—Highlights from the 53rd American Society of Hematology Annual Meeting and Exposition
An interactive CME program provided by Educational Concepts Group, LLC
OncologySTAT CME
Addressing the Risk of TLS in Adult Patients: Case Studies for the Practicing Physician
An interactive CME program provided by Med-IQ
OncologySTAT CME
William Bensinger, MD (Consultservice 1): Practical Aspects of HSCT for Hematologic Malignancies
An interactive CME program powered by Real CME
OncologySTAT CME

News

FDA: Rare Brain Infection Prompts Boxed Warning for Brentuximab
Elsevier Global Medical News, 2012 Jan 13, D Mahoney
'Best Results' Yet for Poor-Prognosis Elderly With DLBCL
Elsevier Global Medical News, 2012 Jan 4, N Osterweil
Cell Therapeutics' Dual Strategy on Pixuvri Will Be Tested at Advisory Committee
The Pink Sheet Daily, 2011 Dec 29, M Berman-Gorvine
Mantle Cell Lymphoma: BTK Inhibitor Scores Again
Elsevier Global Medical News, 2011 Dec 15, N Osterweil
Obinutuzumab Equals Rituximab in Relapsed Indolent NHL
Elsevier Global Medical News, 2011 Dec 13, N Osterweil
More News ›

Journal Scans: Research

Comparative Outcome of Initial Therapy for Younger Patients With Mantle Cell Lymphoma: An Analysis From the NCCN NHL Database
Blood, 2012 Jan 10, AS Lacasce, et al
Randomized Clinical Trial to Assess the Efficacy of Radiotherapy in Primary Mediastinal Large B-Lymphoma
Int J Radiat Oncol Biol Phys, 2011 Dec 13, A Aviles, et al
Sequential Treatment With Rituximab Followed by CHOP Chemotherapy in Adult B-Cell Post-Transplant Lymphoproliferative Disorder (PTLD): The Prospective International Multicentre Phase 2 PTLD-1 Trial
Lancet Oncol, 2011 Dec 13, R Trappe, et al
Interim [18F]Fluorodeoxyglucose Positron Emission Tomography Scan in Diffuse Large B-Cell Lymphoma Treated With Anthracycline-Based Chemotherapy Plus Rituximab
J Clin Oncol, 2011 Dec 12, V Safar, et al
Prognostic Factors in Transformed Mycosis Fungoides: A Retrospective Analysis of 100 Cases
Blood, 2011 Dec 12, MF Benner, et al
More Journal Scans: Research ›

Journal Scans: Review

Second Solid Tumors: Screening and Management Guidelines in Long-Term Survivors After Allogeneic Stem Cell Transplantation
Semin Hematol, 2012 Jan 1, G Socie, et al
Free Journal Content
Prevention of CNS Relapse in Diffuse Large B-Cell Lymphoma
Lancet Oncol, 2011 Dec 1, R Kridel, et al
Low-Grade Follicular Lymphoma of the Small Intestine: A Challenge for Management
Semin Oncol, 2011 Dec 1, N Bennani-Baiti, et al
Hepatosplenic Gamma-Delta T-Cell Lymphoma
Crit Rev Oncol Hematol, 2011 Oct 31, AJ Ferreri, et al
Mantle Cell Lymphoma: The Promise of New Treatment Options
Crit Rev Oncol Hematol, 2011 Oct 1, A Goy, et al
More Journal Scans: Review ›

Expert Opinion

Ask the Expert: Zoledronic Acid in Late-Stage DLBCL With Bone Involvement
2012 Jan 30, Andre Goy, et al
Ask the Expert: Interim PET-CT in Evaluation Lymphoma Treatment Response
2012 Jan 30, Andre Goy, et al
Ask the Expert: Ideal Management of Advanced Gastric DLBCL?
2012 Jan 30, Andre Goy, et al
Ask the Expert: Is it Stage IIS or IIIS Lymphoma?
2012 Jan 30, Andre Goy, et al
Ask the Expert: Efficacy for Post-Transplant Rituximab in Lymphoma
2012 Jan 30, Andre Goy, et al
More Expert Opinion ›

Chemotherapy Regimens

Rituximab/hyper CVAD (cyclophosphamide, vincristine, doxorubicin [Adriamycin], dexamethasone) alternating with methotrexate, – cytarabine (Non-Hodgkin's lymphoma)
The Elsevier Guide to Oncology Drugs & Regimens (2008 edition)
Rituximab/EPOCH (etoposide, prednisone, – vincristine [Oncovin], doxorubicin, cyclophosphamide) (Non-Hodgkin's lymphoma)
The Elsevier Guide to Oncology Drugs & Regimens (2008 edition)
Rituximab/CHOP (cyclophosphamide, doxorubicin, vincristine [Oncovin], prednisone) (Non-Hodgkin's lymphoma)
The Elsevier Guide to Oncology Drugs & Regimens (2008 edition)
Rituximab (Non-Hodgkin's lymphoma)
The Elsevier Guide to Oncology Drugs & Regimens (2008 edition)
Hyper CVAD (cyclophosphamide, vincristine, doxorubicin [Adriamycin], dexamethasone) alternating with methotrexate, cytarabine (Non-Hodgkin's lymphoma)
The Elsevier Guide to Oncology Drugs & Regimens (2008 edition)
More Chemotherapy Regimens ›

Conference Coverage

2011 ASH Annual Meeting and Exposition
Dec 10-13 2011 San Diego, et al
16th Congress of EHA
June 9-12 2011 London

Videos

Bendamustine Plus Rituximab as First-Line Lymphoma Treatment
Elsevier Global Medical News, 2009 Dec 16, P Wendling
Fostamatinib for Leukemia, Lymphoma
Elsevier Global Medical News, 2008 Dec 6, JS MacNeil
National Clinical Trial Underway in Follicular Lymphoma
ASCO, 2007 Jun 4, Edwina Bakin-Bey MD

Summary of Key Points

Non-Hodgkin's Lymphoma
Abeloff's Clinical Oncology, 4th ed. 2008

Updated Key Points: Non-Hodgkin's Lymphoma

Summary information about non-Hodgkin's lymphoma has been completely revised with updated information from Abeloff's Clinical Oncology, 4th ed.
Read more ›

Commentary

Ten Practice Changes I Will Make After Attending ASCO 2011
Read more ›

Cancer Type

  • Bladder
  • Bone
  • Breast
  • Breast (ER-Positive)
  • CNS/Brain
  • Colon and Rectum
  • Endocrine System
  • Esophagus
  • GYN (Non-Ovary)
  • GYN (Ovary)
  • Head and Neck
  • Hodgkin's Lymphoma
  • Kidney (Renal Cell)
  • Leukemia
  • Liver and Bile Duct
  • Lung
  • Multiple Myeloma
  • Myelodysplastic Syndrome
  • Myeloproliferative Diseases
  • Non-Hodgkin's Lymphoma
  • Pancreas
  • Pediatric Cancers
  • Prostate
  • Rare Cancers
  • Skin
  • Soft-Tissue Sarcoma
  • Stomach
  • Testicle
    • Forgot your password?
    Not a member? Free registration